Prehypertension: Clinical Trials

17 trials for Prehypertension, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 4 terminated, 2 unknown, 1 withdrawn. 17 Phase 2, 5 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 217Completed 10, Terminated 4, Unknown 2, Withdrawn 1
Phase 15Completed 2, Unknown 2, Withdrawn 1
Phase 32Completed 2

Follow Prehypertension: new trials by email Literature Review of Prehypertension trials Research Report on Prehypertension

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Early Hypertension Among Persons Living With HIV in Haiti
Amlodipine 5mg - HIV/AIDS, Pre Hypertension
Phase 2CompletedWeill Medical College of Cornell University2502021-02-262024-04-09
Safety and Feasibility of Remote Ischemic Conditioning on Prehypertension and Early-stage Hypertension
remote ischemic conditioning - Prehypertension, Remote Ischemic Conditioning
Phase 1 / Phase 2UnknownCapital Medical University202019-06-302020-02-05
Race, Natriuretic Peptides and Physiological Perturbations
Exercise capacity VO2 max determination, Standardized meals, Exercise challenge - Healthy, Pre Hypertension
Phase 2CompletedUniversity of Alabama at Birmingham802017-04-302025-03-12
A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure
B244, Vehicle - Prehypertension, Hypertension, Stage I
Phase 2CompletedAOBiome LLC1322016-11-012022-09-15
A Study to Investigate the Effect of a Nitric Oxide Supplementation on Pre- and Mildly Hypertensive Adults
Neo40 Daily®, Placebo - Pre-hypertension
Phase 2TerminatedKGK Science Inc.672016-02-032018-04-12
Center of Research Translation (CORT) Project 2
Allopurinol, Placebo - Pre-hypertension, JNC 7 Stage I Hypertension
Phase 2 / Phase 3CompletedUniversity of Alabama at Birmingham992014-07-012021-01-11
Effect and Safety of Marealis RPC (Refined Peptide Concentrate) in Mild or Moderate Hypertensive Subjects
Marealis refined peptide concentrate, Placebo - Prehypertension
Phase 2CompletedKGK Science Inc.1442013-11-012015-12-24
Vascular Dysfunction in Human Obesity Hypertension
Clonidine, Hydrochlorothiazide, Placebo - Obesity, Prehypertension
Phase 2TerminatedGary L. Pierce332013-10-012023-04-14
Study of the Effects of an Oral Nitric Oxide Supplement on Blood Pressure in Prehypertensive Adults
Nitric Oxide supplement, Placebo - Prehypertension
Phase 1 / Phase 2UnknownNeogenis Laboratories302013-01-012013-09-10
Effects and Safety of Menthol on Blood Pressure and Metabolic Parameters in Prehypertensive and Mild Hypertensive Patients
Menthol, Placebo - Hypertension, Prehypertension
Phase 2 / Phase 3CompletedZhiming Zhu362012-08-012020-03-11
Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients
Potassium, Magnesium, Citrate, Potassium Chloride - Pre-hypertension, Hypertension
Phase 1 / Phase 2WithdrawnUniversity of Texas Southwestern Medical Center2009-09-012019-02-11
Primary Prevention of Hypertension in Obese Adolescents
Allopurinol, Probenecid, Placebo - Obesity, Pre-Hypertension
Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)602008-09-012017-09-14
Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease
carvedilol phosphate, lisinopril, carvedilol phosphate and lisinopril - Pre-hypertension
Phase 1 / Phase 2CompletedUniversity of Minnesota1012007-11-012018-04-24
Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects
losartan, hydrochlorothiazide - Pre-hypertension, Pre-diabetes
Phase 2TerminatedSir Mortimer B. Davis - Jewish General Hospital12007-03-012015-05-19
Telephone-Based Lifestyle Intervention to Reduce Blood Pressure in Prehypertensive Patients
Telephone-based lifestyle counseling - High Blood Pressure
Phase 2TerminatedNYU Langone Health1252007-01-012013-11-19
Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension
Drospirenone/17ß-estradiol (Angeliq, BAY86-4891), SH K 00641 C - Medroxyprogesterone acetate / conjugated equine (Prempro TM) - Postmenopause, Hypertension
Phase 2CompletedBayer922007-01-012015-06-02
The Effect of Hibiscus Sabdariffa L. Tea on Blood Pressure
herbal therapy/botanical therapy (Hibiscus sabdariffa) - Hypertension
Phase 1 / Phase 2CompletedTufts University662009-12-03

Narrower conditions

Hypertension (10)  ·  Obesity (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Glucose Intolerance (1)  ·  Hyperuricemia (1)

Broader conditions

Cardiovascular Diseases (17)  ·  Vascular Diseases (17)  ·  Nutritional and Metabolic Diseases (3)  ·  Body Weight (2)  ·  Nutrition Disorders (2)  ·  Overnutrition (2)  ·  Overweight (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  HIV Infections (1)  ·  Hyperglycemia (1)

Interventions

Allopurinol (2)  ·  Amlodipine (1)  ·  Carvedilol (1)  ·  Clonidine (1)  ·  Hydrochlorothiazide (1)  ·  Lisinopril (1)  ·  Losartan (1)  ·  Menthol (1)  ·  Metoprolol (1)  ·  Phytotherapy (1)  ·  Potassium Chloride (1)  ·  Probenecid (1)  ·  estradiol-drospirenone combination (1)  ·  hydrochlorothiazide, losartan drug combination (1)  ·  potassium-magnesium citrate (1)

Sponsors

KGK Science Inc. (2)  ·  University of Alabama at Birmingham (2)  ·  AOBiome LLC (1)  ·  Bayer (1)  ·  Capital Medical University (1)  ·  Gary L. Pierce (1)  ·  NYU Langone Health (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Neogenis Laboratories (1)  ·  Sir Mortimer B. Davis - Jewish General Hospital (1)  ·  Tufts University (1)  ·  University of Minnesota (1)  ·  University of Texas Southwestern Medical Center (1)  ·  Weill Medical College of Cornell University (1)  ·  Zhiming Zhu (1)

Countries

United States (12)  ·  Canada (3)  ·  China (2)  ·  Czechia (1)  ·  Germany (1)  ·  Haiti (1)

Top investigators

Dale Wilson, MD (1)  ·  Daniel I Feig, MD, PhD (1)  ·  Ernesto L. Schiffrin, MD, PhD (1)  ·  Ernst Schwarz, MD, PhD (1)  ·  Gary L Pierce, PhD (1)  ·  Jay N Cohn, MD (1)  ·  Jean Pape (1)  ·  Jeffrey B Blumberg, Ph.D. (1)  ·  Larry Weiss, MD (1)  ·  Margaret McNairy, MD (1)  ·  Matthew M Burg (1)  ·  Pankaj Arora, MD (1)  ·  Tanya M Goyal, PhD (1)  ·  Tetyana Pelipyagina, MD (1)

Results publications

PMID 11581560, PMID 16476851, PMID 20018807, PMID 21849262, PMID 23006736, PMID 24637663, PMID 31467699, PMID 33779064, PMID 34351939, PMID 34493347, PMID 39761592, PMID 39948072, PMID 9134374, PMID 9357812

NIH funding

K23HL146887 (1), P50AR060772 (1), R21DK071223 (1), R21TW011693 (1)